Literature DB >> 27838702

Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak.

Rita F Redberg1,2, Mitchell H Katz3,4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27838702     DOI： 10.1001/jama.2016.15085

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  Assessing the Relationship Between American Heart Association Atherosclerotic Cardiovascular Disease Risk Score and Coronary Artery Imaging Findings.

Authors:  Ying Li; Guangming Zhu; Victoria Ding; Bin Jiang; Robyn L Ball; Neera Ahuja; Fatima Rodriguez; Dominik Fleischmann; Manisha Desai; David Saloner; Luca Saba; Max Wintermark; Jason Hom
Journal:  J Comput Assist Tomogr       Date:  2018 Nov/Dec       Impact factor: 1.826

2.  How Common is Statin Use in the Oldest Old?

Authors:  Wade Thompson; Anton Pottegård; Jesper Bo Nielsen; Peter Haastrup; Dorte Ejg Jarbøl
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

3.  Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort.

Authors:  Paula Byrne; John Cullinan; Paddy Gillespie; Rafael Perera; Susan M Smith
Journal:  Br J Gen Pract       Date:  2019-04-23       Impact factor: 5.386

4.  Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease.

Authors:  Chris J Packard; Robin Young; Kevin Ross; Ian Ford; Baishali M Ambegaonkar; Philippe Brudi; Colin McCowan
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-10-01

5.  Functional principal component based landmark analysis for the effects of longitudinal cholesterol profiles on the risk of coronary heart disease.

Authors:  Bin Shi; Peng Wei; Xuelin Huang
Journal:  Stat Med       Date:  2020-11-05       Impact factor: 2.497

6.  Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.

Authors:  Jelena Pavlović; Philip Greenland; Jaap W Deckers; Maryam Kavousi; Albert Hofman; M Arfan Ikram; Oscar H Franco; Maarten Jg Leening
Journal:  Eur J Prev Cardiol       Date:  2017-11-24       Impact factor: 7.804

7.  Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?

Authors:  Carissa Bonner; Katy Bell; Jesse Jansen; Paul Glasziou; Les Irwig; Jenny Doust; Kirsten McCaffery
Journal:  BMC Cardiovasc Disord       Date:  2018-02-07       Impact factor: 2.298

8.  Online decision aids for primary cardiovascular disease prevention: systematic search, evaluation of quality and suitability for low health literacy patients.

Authors:  Carissa Bonner; Pinika Patel; Michael Anthony Fajardo; Ruixuan Zhuang; Lyndal Trevena
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

9.  Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice.

Authors:  Jesse Jansen; Shannon McKinn; Carissa Bonner; Danielle Marie Muscat; Jenny Doust; Kirsten McCaffery
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

10.  Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline.

Authors:  Marco D Huesch
Journal:  Drugs R D       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.